| Descriptor English: | Integrin alphaXbeta2 | ||||||
| Descriptor Spanish: |
Integrina alfaXbeta2
| ||||||
| Descriptor Portuguese: | Integrina alfaXbeta2 | ||||||
| Descriptor French: | Intégrine alphaX bêta2 | ||||||
| Entry term(s): |
Antigen p150,95 Antigen, p150,95 CR4 Receptor Complement Receptor 4 Complement Receptor Type 4 GP150, Neutrophil Glycoprotein Gp150, Neutrophil Glycoprotein, p150,95 Gp150, Neutrophil Glycoprotein Integrin, alphaXbeta2 Leukocyte Adhesion Protein p150,95 Neutrophil GP150 Neutrophil Glycoprotein Gp150 Receptor, CR4 alphaXbeta2 Integrin alphaXbeta2, Integrin p150,95 Antigen p150,95 Glycoprotein |
||||||
| Tree number(s): |
D12.776.395.550.200.275 D12.776.543.550.200.275 D12.776.543.750.705.408.600.100 D12.776.543.750.705.833.249 D23.050.301.350.275 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016167 | ||||||
| Scope note: | A major adhesion-associated heterodimer molecule expressed by MONOCYTES; GRANULOCYTES; NK CELLS; and some LYMPHOCYTES. The alpha subunit is the CD11C ANTIGEN, a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 ANTIGEN. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Previous Indexing: |
Antigens, Differentiation (1988-1990) Receptors, Leukocyte-Adhesion (1989-1990) |
||||||
| Public MeSH Note: | 2003; see COMPLEMENT 4-BINDING PROTEIN 2002, see ANTIGEN P150,95 1991-2001; INTEGRIN APHAXBETA2 was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 & GLYCOPROTEINS 1985-1987 |
||||||
| History Note: | 2003 (1991); use INTEGRIN ALPHAXBETA2 (NM) 1985-2002 |
||||||
| DeCS ID: | 28862 | ||||||
| Unique ID: | D016167 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1991/01/01 | ||||||
| Date of Entry: | 1990/04/24 | ||||||
| Revision Date: | 2006/07/05 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Integrin alphaXbeta2
- Preferred
| Concept UI |
M0024681 |
| Scope note | A major adhesion-associated heterodimer molecule expressed by MONOCYTES; GRANULOCYTES; NK CELLS; and some LYMPHOCYTES. The alpha subunit is the CD11C ANTIGEN, a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 ANTIGEN. |
| Preferred term | Integrin alphaXbeta2 |
| Entry term(s) |
Antigen p150,95 Antigen, p150,95 CR4 Receptor Complement Receptor 4 Complement Receptor Type 4 GP150, Neutrophil Glycoprotein Gp150, Neutrophil Glycoprotein, p150,95 Gp150, Neutrophil Glycoprotein Integrin, alphaXbeta2 Leukocyte Adhesion Protein p150,95 Neutrophil GP150 Neutrophil Glycoprotein Gp150 Receptor, CR4 alphaXbeta2 Integrin alphaXbeta2, Integrin p150,95 Antigen p150,95 Glycoprotein |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
